title: Effect of a neutralizing monoclonal antibody to cholesteryl ester transfer protein on the redistribution of apolipoproteins A-IV and E among human lipoproteins.
abstract: The effect of inhibiting cholesteryl ester transfer protein (CETP) on the in vitro redistribution of apolipoproteins(apo) A-IV and apoE among lipoproteins in whole plasma was studied in seven normal male subjects. Plasmas were incubated in the presence of a purified monoclonal antibody TP2 (Mab TP2) that neutralizes the activity of CETP. Mab TP2 had no effect on lecithin:cholesterol acyltransferase (LCAT) activity. Prior to and following a 6-h incubation at 37 degrees C in the presence of Mab TP2 or a control mouse myeloma immunoglobulin (IgG), plasmas were gel-filtered on Sephacryl S-300 and the distribution of apoA-IV and apoE among lipoproteins was determined by radioimmunoassay. Incubation (i.e., with active LCAT and CETP) increased the amount of apoA-IV associated with lipoproteins by 240%. When CETP activity was inhibited during incubation, the amount of apoA-IV that became lipoprotein-associated was significantly increased (315% of basal). Plasma incubation also caused a redistribution of apoE from high density lipoproteins (HDL) to larger lipoproteins (131% of basal); however, when CETP was inhibited, significantly greater amounts of apoE became associated with the larger particles (155% of basal). These effects were observed in all seven subjects. Increased movement of apoE from HDL to triglyceride-rich particles was not due to displacement by apoA-IV since loss of apoE from HDL was still observed when no movement of apoA-IV onto HDL occurred, such as during LCAT or combined LCAT and CETP inhibition. We speculate that low CETP activity (e.g., in species such as rats) may lead to an increased content of HDL apoA-IV and also to apoE enrichment of triglyceride-rich lipoproteins, augmenting their clearance.
authors: Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032.
authors: C L
authors: CL
authors: Bisgaier
authors: M V
authors: MV
authors: Siebenkas
authors: C B
authors: CB
authors: Hesler
authors: T L
authors: TL
authors: Swenson
authors: C B
authors: CB
authors: Blum
authors: Y L
authors: YL
authors: Marcel
authors: R W
authors: RW
authors: Milne
authors: R M
authors: RM
authors: Glickman
authors: A R
authors: AR
authors: Tall
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology; D001054:Apolipoproteins A / Q000097:blood*; D001057:Apolipoproteins E / Q000097:blood*; D002352:Carrier Proteins / Q000097:blood* / Q000276:immunology; D053480:Cholesterol Ester Transfer Proteins; D002850:Chromatography, Gel; D004591:Electrophoresis, Polyacrylamide Gel; D006023:Glycoproteins; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D002785:Sterol O-Acyltransferase / Q000097:blood; D014280:Triglycerides / Q000097:blood
chemical_list: D000911:Antibodies, Monoclonal; D001054:Apolipoproteins A; D001057:Apolipoproteins E; C506642:CETP protein, human; D002352:Carrier Proteins; D053480:Cholesterol Ester Transfer Proteins; D006023:Glycoproteins; D008074:Lipoproteins; D014280:Triglycerides; C022205:apolipoprotein A-IV; D002785:Sterol O-Acyltransferase